Metis Global Partners »

Taro Pharmaceutical Industries shares owned by Metis Global Partners

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Metis Global Partners from 13F filings

Historical chart of Metis Global Partners investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by Metis Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by Metis Global Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $294k 6.9k 42.34
2023-12-31 $290k 6.9k 41.78
2023-09-30 $262k 6.9k 37.71
2021-12-31 $766k 15k 50.17

More positions owned by Metis Global Partners

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Abrdn Gold Etf Trust Physcl Gold Shs (SGOL)
Abrdn Etfs Bbrg All Comd K1 (BCI)
Ishares Tr Core Msci Euro (IEUR)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Metis Global Partners

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
Dimensional Fund Advisors
Brandes Investment Partners
Vanguard Group
ARK Investment Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management
Swiss National Bank
Citadel Advisors
Barclays
Connor, Clark & Lunn Investment Management
Inspire Advisors

View all funds holding Taro Pharmaceutical Industries